Puma Biotechnology Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$54,475	$52,436	$46,007	$59,077
Gross Profit	42,302	40,135	35,451	45,156
EBITDA	13,454	10,765	8,240	17,700
EBIT	10,732	8,002	5,444	14,859
Net Income	8,844	5,855	2,974	19,305
Net Change In Cash	54,475	52,436	46,007	59,077
Free Cash Flow	9,663	14,062	3,551	15,591
Cash	53,525	54,662	63,030	69,219
Basic Shares	50,929	50,144	49,906	49,408

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$230,468	$235,637	$228,031	$253,155
Gross Profit	166,064	172,955	172,938	189,454
EBITDA	48,076	47,523	21,889	-4,690
EBIT	36,552	36,004	12,049	-15,995
Net Income	30,278	21,591	2	-29,126
Net Change In Cash	230,468	235,637	228,031	253,155
Cost of Revenue			3,500	-22,162
Free Cash Flow	38,862	14,369	-22,827	20,650
Cash	69,219	84,585	76,201	63,131
Basic Shares	49,100	47,550	44,929	40,638